A Pharmacodynamic Markov Mixed-Effects Model for Determining the Effect of Exposure to Certolizumab Pegol on the ACR20 Score in Patients With Rheumatoid Arthritis-Reference-Cited by-同舟云学术

A Pharmacodynamic Markov Mixed-Effects Model for Determining the Effect of Exposure to Certolizumab Pegol on the ACR20 Score in Patients With Rheumatoid Arthritis

Published:2009-07-22 Issue:4 Volume:86 Page:387-395
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Lacroix B D,Lovern M R,Stockis A,Sargentini-Maier M L,Karlsson M O,Friberg L E

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference28 articles.

1. Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis

2. Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum

3. Role of cytokines in inflammatory synovitis

4. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis;Rheumatology;2024-09-02

2. Exposure–response modeling for nausea incidence for cotadutide using a Markov modeling approach;CPT: Pharmacometrics & Systems Pharmacology;2024-07-23

3. Practical Applications of a Nausea and Vomiting Model in the Clinical Development of Additional Doses of Dulaglutide;The Journal of Clinical Pharmacology;2023-10-29

4. A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohorts;CPT: Pharmacometrics & Systems Pharmacology;2023-10-03

5. Seasonal influence on respiratory tract infection severity including COVID‐19 quantified through Markov Chain modeling;CPT: Pharmacometrics & Systems Pharmacology;2023-07-10